NCT01071746View on ClinicalTrials.gov

Predictive Utility of DASIMAR as a Prognostic Biomarker in Acute-on-chronic Liver Failure (ACLF)

UnknownOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Liver Cirrhosis
Trial Locations (1)

WC1E 6HX

RECRUITING

University College London Hospital, London

Sponsors

Collaborators (1)

Medical Research Council
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

lead

University College London Hospitals

OTHER